tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Entero Therapeutics Approves Key Proposals at Annual Meeting

Story Highlights
  • Entero Therapeutics held its Annual Meeting on June 30, 2025, approving all five proposals.
  • Key approvals included director elections, a potential reverse stock split, and executive compensation.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Entero Therapeutics Approves Key Proposals at Annual Meeting

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest announcement is out from Entero Therapeutics ( (ENTO) ).

On June 30, 2025, Entero Therapeutics, Inc. held its Annual Meeting of Stockholders, where all five proposals were approved. The stockholders elected five directors to the board for a one-year term and approved a potential reverse stock split of the company’s common stock. Additionally, the executive compensation plan was approved, the appointment of Machias Gini & O’Connell LLP as the independent accounting firm was ratified, and the possibility of adjourning the meeting due to insufficient proxies was sanctioned.

More about Entero Therapeutics

Average Trading Volume: 1,652,613

Technical Sentiment Signal: Strong Sell

Current Market Cap: $1.86M

Find detailed analytics on ENTO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1